Science
Nanoparticle Design Paves Way for Improved Detection of Tumors – Novus Light Today – Novus Light Technologies Today
A research team from KTH Royal Institute of Technology is combining optical and X-ray fluorescence contrast agents into a single enhancer for both modes.
In order to enhance visual contrast of living tissues, state-of-the-art imaging relies on agents such as fluorescent dyes and biomolecules. Advances in nanoparticle research have expanded the array of promising contrast agents for more targeted diagnostics, and now a research team from KTH Royal Institute of Technology has raised the bar further yet. They are combining optical and X-ray fluorescence contrast agents into a single enhancer for both modes.
Muhammet Toprak, Professor of Materials Chemistry…
-
Business18 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News18 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business22 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business21 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025